Close
Back to MDGL Stock Lookup

Madrigal Pharma (MDGL) – Hot FDA News

Mar 14, 2024 04:16 PM Madrigal Pharma (MDGL) Confirms FDA Approval of Rezdiffra for Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
Mar 14, 2024 03:52 PM Madrigal Pharma (MDGL): FDA Approves rezdiffra
Mar 14, 2024 03:45 PM
Dec 19, 2022 07:00 AM
Jan 31, 2022 07:00 AM
May 31, 2018 07:01 AM
Dec 6, 2017 06:58 AM

Back to MDGL Stock Lookup